Contrasting Journey Medical (NASDAQ:DERM) and Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) and Journey Medical (NASDAQ:DERM – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.

Profitability

This table compares Shionogi & Co., Ltd. Unsponsored ADR and Journey Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Shionogi & Co., Ltd. Unsponsored ADR 37.95% 14.32% 10.24%
Journey Medical -7.34% -16.07% -5.26%

Earnings & Valuation

This table compares Shionogi & Co., Ltd. Unsponsored ADR and Journey Medical”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Shionogi & Co., Ltd. Unsponsored ADR $3.32 billion 5.14 $1.35 billion $0.90 11.13
Journey Medical $61.86 million 1.78 -$11.43 million ($0.18) -21.65

Shionogi & Co., Ltd. Unsponsored ADR has higher revenue and earnings than Journey Medical. Journey Medical is trading at a lower price-to-earnings ratio than Shionogi & Co., Ltd. Unsponsored ADR, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Shionogi & Co., Ltd. Unsponsored ADR has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500. Comparatively, Journey Medical has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Shionogi & Co., Ltd. Unsponsored ADR and Journey Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shionogi & Co., Ltd. Unsponsored ADR 0 0 0 3 4.00
Journey Medical 2 0 2 0 2.00

Journey Medical has a consensus price target of $13.00, suggesting a potential upside of 233.59%. Given Journey Medical’s higher possible upside, analysts clearly believe Journey Medical is more favorable than Shionogi & Co., Ltd. Unsponsored ADR.

Institutional & Insider Ownership

1.9% of Shionogi & Co., Ltd. Unsponsored ADR shares are held by institutional investors. Comparatively, 7.2% of Journey Medical shares are held by institutional investors. 14.5% of Journey Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Shionogi & Co., Ltd. Unsponsored ADR beats Journey Medical on 10 of the 15 factors compared between the two stocks.

About Shionogi & Co., Ltd. Unsponsored ADR

(Get Free Report)

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker. The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova.

About Journey Medical

(Get Free Report)

Journey Medical Corporation is a commercial-stage pharmaceutical company focused on developing and marketing prescription treatments for dermatological conditions. Founded in 2014 and based in Scottsdale, Arizona, the company primarily serves the U.S. market. Its portfolio includes treatments for conditions such as acne, rosacea, excessive underarm sweating and fungal skin infections. Products include Amzeeq and Zilxi, topical minocycline therapies; Qbrexza, a topical treatment for primary axillary hyperhidrosis; and the oral rosacea treatment Emrosi.

Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.